Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Justin T Puckett"'
Publikováno v:
Immunotherapy. 14:741-753
Chimeric antigen receptor T cells are a potentially curative new therapeutic option, but access challenges remain. The limited number of certified treatment centers and the need to travel to these centers, the expenses of travel and lodging and the o
Autor:
Erik R Dubberke, Justin T Puckett, Engels N Obi, Sachin Kamal-Bahl, Kaushal Desai, Bruce Stuart, Jalpa A Doshi
Publikováno v:
Open Forum Infectious Diseases. 9
Background The 2017 Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) Clostridium (Clostridioides) difficile infection (CDI) guideline update recommended treatment with fidaxomicin or vancomycin for CDI
Autor:
Scott F Huntington, Beenish S Manzoor, Justin T Puckett, Sachin Kamal-Bahl, Hasan Alhasani, Arliene Ravelo, Mahesh Fuldeore, Jalpa A Doshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S277-S278
Autor:
Daniel J. Rader, Michael S. Parmacek, Pengxiang Li, Justin T. Puckett, Amy R. Pettit, Swathi Raman, Jalpa A. Doshi
Publikováno v:
Value in Health. 23:209-216
Objectives Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is)—innovative yet costly cholesterol-lowering agents—have been subject to substantial prior authorization (PA) requirements and low approval rates. We aimed to investigate
Autor:
Erik R, Dubberke, Justin T, Puckett, Engels N, Obi, Sachin, Kamal-Bahl, Kaushal, Desai, Bruce, Stuart, Jalpa A, Doshi
Publikováno v:
Open forum infectious diseases. 9(10)
The 2017 Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA)A pre-post study design was employed using Medicare data. CDI treatment utilization and clinical outcomes (4- and 8-week sustained response, CDI
Autor:
Christopher R Manz, Justin T. Puckett, Victoria T Brown, Pengxiang Li, Jordan Jahnke, Jalpa A. Doshi, Swathi Raman, Melea A Ward
Publikováno v:
Journal of managed carespecialty pharmacy. 27(10)
BACKGROUND: Few studies have examined oral anticancer treatment utilization patterns among Medicare beneficiaries. OBJECTIVE: To assess treatment utilization patterns of newly initiated oral anticancer agents across national samples of Medicare benef
Autor:
Scott F Huntington, Beenish S Manzoor, Justin T Puckett, Sachin Kamal-Bahl, Hasan Alhasani, Arliene Ravelo, Mahesh Fuldeore, Jalpa A Doshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S143
Publikováno v:
Journal of Clinical Pathways. 5:44-47
Autor:
Erik R. Dubberke, Justin T. Puckett, Engels N. Obi, Sachin Kamal-Bahl, Kaushal Desai, Bruce Stuart, Jalpa A. Doshi
Publikováno v:
Gastroenterology. 162:S-157
Autor:
Jalpa A. Doshi, Justin T. Puckett, Pengxiang Li, Michael S. Parmacek, Daniel J. Rader, Amy R. Pettit
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 13
Background: Specialty drugs are typically subject to high out-of-pocket (OOP) costs, especially for Medicare Part D patients and commercially insured patients facing high deductibles and/or coinsurance. Financial assistance offered by charities or ma